New CRISPR-Cas9 approach confers protection from ischemia/reperfusion injury

A new CRISPR-Cas9 approach that targets a detrimental signaling pathway in the heart confers protection from ischemia/reperfusion injury, according to a study in mice.

Related Keywords

Eric Olson ,Simon Lebek ,Emily Henderson , ,Genomics Industry Focus ,Cas9 ,Rispr ,Gene ,Heart ,Heart Attack ,Heart Disease ,Ortality ,Ignaling Pathway ,